Related references
Note: Only part of the references are listed.An ABC Transporter Controls Export of a Drosophila Germ Cell Attractant
Sara Ricardo et al.
SCIENCE (2009)
Accelerated ageing: from mechanism to therapy through animal models
Fernando G. Osorio et al.
TRANSGENIC RESEARCH (2009)
HIV-protease inhibitors block the enzymatic activity of purified Ste24p
Sarah E. Hudon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblings
Y. Miyoshi et al.
CLINICAL GENETICS (2008)
Premature aging in mice activates a systemic metabolic response involving autophagy induction
Guillermo Marino et al.
HUMAN MOLECULAR GENETICS (2008)
A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells
Catherine Coffinier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Nuclear envelope defects cause stem cell dysfunction in premature-aging mice
Jesus Espada et al.
JOURNAL OF CELL BIOLOGY (2008)
Analysis of Prelamin A Biogenesis Reveals the Nucleus to be a CaaX Processing Compartment
Jemima Barrowman et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing
Paola Scaffidi et al.
NATURE CELL BIOLOGY (2008)
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
Ignacio Varela et al.
NATURE MEDICINE (2008)
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model
Brian C. Capell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Mutant Form of Lamin A that Causes Hutchinson-Gilford Progeria Is a Biomarker of Cellular Aging in Human Skin
Dayle McClintock et al.
PLOS ONE (2007)
Small-molecule inhibitors of the Rce1p CaaX protease
Surya P. Manandhar et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence
M. Caron et al.
CELL DEATH AND DIFFERENTIATION (2007)
Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes
Casey L. Moulson et al.
HUMAN MUTATION (2007)
HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells
Catherine Coffinier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms of cardiovascular disease in accelerated aging syndromes
Brian C. Capell et al.
CIRCULATION RESEARCH (2007)
Lipodystrophies: Windows on adipose biology and metabolism
Robert A. Hegele et al.
JOURNAL OF LIPID RESEARCH (2007)
Laminopathies: A wide spectrum of human diseases
Howard J. Worman et al.
EXPERIMENTAL CELL RESEARCH (2007)
Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones
Stephen B. Porter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The prelamin A pre-peptide induces cardiac and skeletal myoblast differentiation
Gary L. Brodsky et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging
Thomas Dechat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions
C. L. Ramirez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Prelamin A farnesylation and progeroid syndromes
Stephen G. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human laminopathies: nuclei gone genetically awry
Brian C. Capell et al.
NATURE REVIEWS GENETICS (2006)
DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A
Yiyong Liu et al.
JOURNAL OF CELL SCIENCE (2006)
The laminopathies: a clinical review
J. Rankin et al.
CLINICAL GENETICS (2006)
Protein farnesyltransferase inhibitors and progeria
Margarita Meta et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Therapeutic intervention based on protein prenylation and associated modifications
Michael H. Gelb et al.
NATURE CHEMICAL BIOLOGY (2006)
Saccharomyces cerevisiae a-factor mutants reveal residues critical for processing, activity, and export
Gregory Huyer et al.
EUKARYOTIC CELL (2006)
Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors
Antonio E. Rusinol et al.
JOURNAL OF CELL SCIENCE (2006)
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation
Shao H. Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Nuclear lamins: Laminopathies and their role in premature ageing
J. L. V. Broers et al.
PHYSIOLOGICAL REVIEWS (2006)
Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging
Dale K. Shumaker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nuclear lamins, diseases and aging
Anna Mattout et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation 4 in the LMNA gene causes Hutchinson-Gilford progerlia syndrome (HGPS):: Insights into the pathophysiology of HGPS
Jonas Denecke et al.
HUMAN MUTATION (2006)
Lamin A-dependent nuclear defects in human aging
P Scaffidi et al.
SCIENCE (2006)
CAAX modification and membrane targeting of Ras
Latasha P. Wright et al.
JOURNAL OF LIPID RESEARCH (2006)
A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria
LG Fong et al.
SCIENCE (2006)
Farnesyl transferase inhibitors
AD Basso et al.
JOURNAL OF LIPID RESEARCH (2006)
Prelamin A, Zmpste24, misshapen cell nuclei, and progeria - new evidence suggesting that protein farnesylation could be important for disease pathogenesis
SG Young et al.
JOURNAL OF LIPID RESEARCH (2005)
Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile
M Schuldiner et al.
CELL (2005)
The cell nucleus and aging: Tantalizing clues and hopeful promises
P Scaffidi et al.
PLOS BIOLOGY (2005)
Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy
CL Moulson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition
MW Glynn et al.
HUMAN MOLECULAR GENETICS (2005)
Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome
MP Mallampalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
I Varela et al.
NATURE (2005)
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome
BC Capell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes
JI Toth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation
SH Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genomic instability in laminopathy-based premature aging
BH Liu et al.
NATURE MEDICINE (2005)
Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors
CL Navarro et al.
HUMAN MOLECULAR GENETICS (2005)
Opinion - Post-prenylation-processing enzymes as new targets in oncogenesis
AM Winter-Vann et al.
NATURE REVIEWS CANCER (2005)
The nuclear lamina comes of age
Y Gruenbaum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice
LG Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy
CL Navarro et al.
HUMAN MOLECULAR GENETICS (2004)
Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation
M Caron et al.
AIDS (2003)
Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia
AK Agarwal et al.
HUMAN MOLECULAR GENETICS (2003)
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
M Eriksson et al.
NATURE (2003)
Identification, functional expression and enzymic analysis of two distinct CaaX proteases from Caenorhabditis elegans
J Cadiñanos et al.
BIOCHEMICAL JOURNAL (2003)
Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect
MO Bergo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Yeast genes controlling responses to topogenic signals in a model transmembrane protein
DJ Tipper et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
The multispanning membrane protein Ste24p catalyzes CAAX proteolysis and NH2-terminal processing of the yeast a-factor precursor
A Tam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Biochemical studies of Zmpste24-deficient mice
GK Leung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities
CE Trueblood et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation
KJ Travers et al.
CELL (2000)
Share Paper
